25T2-NBOMe, also known as N-(2-methoxybenzyl)-4-ethylthio-2,5-dimethoxyphenethylamine, is a serotonergic psychedelic of the 25-NB (NBOMe) family. It is the NBOMe analogue of 2C-T-2.
25T2-NBOMe's reported active dose range in humans has been described as 100 to 1,000üg, with a typical dose estimate of 500üg. The route is sublingual administration.
25T2-NBOMe acts as a highly potent and selective agonist of the serotonin 5-HT<sub>2</sub> receptors. Its affinities and activities at a variety of other receptors and transporters have also been described.
25T2-NBOMe was first described in the scientific literature by at least 2012.
25T2-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.